Anti-KRT17 Antibody (R3Q95)

Catalog No.

RHG01702

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000

Target

Keratin-17, CK-17, Cytokeratin-17, 39.1, Keratin, type I cytoskeletal 17, K17, KRT17

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q04695

Applications

IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.5% BSA, 0.05% Sodium Azide and 50% Glycerol.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3Q95

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach., PMID:39935174

D2-40 and CK17 Immunohistochemistry as a Diagnostic Adjunct for HPV-Independent Squamous Lesions in the Vulva and Their Role in Defining Atypical Lichen Sclerosus., PMID:39285528

Current knowledge on autoantigens and autoantibodies in psoriasis., PMID:32697368

The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling., PMID:26694548

Scalable in situ hybridization on tissue arrays for validation of novel cancer and tissue-specific biomarkers., PMID:22412953

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma., PMID:21517111

Document Download

Anti-KRT17 Antibody (R3Q95).pdf